Skip to content

United Laboratories International Holdings Ltd Sustainability Reports

A pharmaceutical group engaged in the research, development, manufacturing, and sales of intermediates, bulk medicine (APIs), and finished medicines, with a focus on antibiotic and insulin products.

Sector: Manufacturing

Country: Hong Kong

Exchange: Hong Kong Stock Exchange

LEI: 2549007JL3XIH77JXN70

FIGI: BBG001SPMVX2

17 reports from 2015 to 2025